Abstract:Interphotoreceptor retinoid-binding protein (IRBP) greatly enhances the conversion of all- trans -retinol to 11- cis -retinal by the retinal pigment epithelium (RPE) and facilitates 11- cis -retinal release from the RPE. However, the mechanisms by which IRBP exerts these effects are not clear. Using a model system of purified bovine IRBP and isolated bovine RPE membranes, we investigated the possibility that IRBP may favor the delivery of all- trans -retinol to, or the release of 11- cis -retinal from, RPE membranes. As the interphotoreceptor space contains serum retinol-binding protein (RBP) and serum albumin in addition to IRBP, we similarly examined the exchange of retinoids between RPE membranes and human RBP or bovine serum albumin (BSA). Isolated RPE membranes were loaded with radioactive 11- cis -retinal and incubated with solutions of IRBP, RBP, BSA or with buffer alone. Membranes (pellet) and retinoid-binding protein or buffer (supernatant) were separated by centrifugation and analysed for radioactive 11- cis -retinal. Membranes incubated with buffer alone released only 4-5% of their 11- cis -retinal, while 25 microm IRBP removed 18-35%. More retinal was released as the membrane concentration was reduced. In contrast, RBP and BSA removed little retinal, even though both proteins are capable of binding this retinoid. Similar results were obtained with bovine liver membranes, consistent with the idea that the effects of IRBP do not depend on an RPE surface receptor for IRBP. IRBP was also markedly superior to RBP and BSA in removing all- trans -retinol from RPE membranes. In addition, IRBP efficiently delivered bound all- trans -retinol to membranes; however, in contrast to their differential removal of retinoids, all three binding proteins delivered comparable amounts of retinol to membranes. (This result supports the practice of using BSA as a retinoid carrier in in vitro experimental systems). We conclude that, whereas IRBP shares with other retinoid-binding proteins the ability to deliver retinol to membranes, IRBP is unique in its capacity to remove 11- cis -retinal from membranes. This may be the feature of IRBP that drives the vitamin A cycle to efficiently produce 11- cis -retinal.

Random Effects Models for Analyzing Mixed Overdispersed Binomial and Normal Longitudinal Responses With Application to Kidney Function Data of Cancer Patients

Linear mixed effects models for non‐Gaussian continuous repeated measurement data

Bayesian Latent-Class Mixed-Effect Hybrid Models for Dyadic Longitudinal Data with Non-Ignorable Dropouts.

Mixed‐Effect Hybrid Models for Longitudinal Data with Nonignorable Dropout

Bayesian Regression Analysis of Data with Random Effects Covariates from Nonlinear Longitudinal Measurements

Bayesian Modeling Longitudinal Dyadic Data with Nonignorable Dropout, with Application to a Breast Cancer Study

Modeling Time-Dependent Overdispersion in Longitudinal Count Data

Efficient Estimation for Patient-Specific Rates of Disease Progression Using Nonnormal Linear Mixed Models

IRBP enhances removal of 11- cis -retinaldehyde from isolated RPE membranes.

Approximate Inferences for Nonlinear Mixed Effects Models with Scale Mixtures of Skew-Normal Distributions

A robust regression model for bounded count health data

Robust Bayesian cumulative probit linear mixed models for longitudinal ordinal data

Bayesian semiparametric joint modeling of a count outcome and inconveniently timed longitudinal predictors

Application of Beta-Distribution and Combined Uniform and Binomial Methods in Longitudinal Modeling of Bounded Outcome Score Data

Linear Mixed-Effects Models for Non-Gaussian Repeated Measurement Data

Semiparametric Bayesian Analysis for Longitudinal Mixed Effects Models with Non-Normal AR(1) Errors

Random Effects Logistic Models for Analysing Efficacy of a Longitudinal Randomized Treatment with Non‐adherence

Regression models for mixed Poisson and continuous longitudinal data.

[Initial clinical experience with a new percutaneous peripheral atherectomy device for the treatment of femoro-popliteal stenoses].

Joint analysis of nonlinear heterogeneous longitudinal data and binary outcome: an application to AIDS clinical studies

An approach for jointly modeling multivariate longitudinal measurements and discrete time-to-event data